Molecular Communication-Based Intelligent Dopamine Rate Modulator for Parkinson's Disease Treatment

Elham Baradari and,Ozgur B Akan

2024-03-25

Abstract:Parkinson's disease (PD) is a progressive neurodegenerative disease, and it is caused by the loss of dopaminergic neurons in the basal ganglia (BG). Currently, there is no definite cure for PD, and available treatments mainly aim to alleviate its symptoms. Due to impaired neurotransmitter-based information transmission in PD, molecular communication-based approaches can be employed as potential solutions to address this issue. Molecular Communications (MC) is a bio-inspired communication method utilizing molecules for carrying information. This mode of communication stands out for developing bio-compatible nanomachines for diagnosing and treating, particularly in addressing neurodegenerative diseases like PD, due to its compatibility with biological systems. This study presents a novel treatment method that introduces an Intelligent Dopamine Rate Modulator (IDRM), which is located in the synaptic gap between the substantia nigra pars compacta (SNc) and striatum to compensate for insufficiency dopamine release in BG caused by PD. For storing dopamine in the IDRM, dopamine compound (DAC) is swallowed and crossed through the digestive system, blood circulatory system, blood-brain barrier (BBB), and brain extracellular matrix uptakes with IDRMs. Here, the DAC concentration is calculated in these regions, revealing that the required exogenous dopamine consistently reaches IDRM. Therefore, the perpetual dopamine insufficiency in BG associated with PD can be compensated. This method reduces drug side effects because dopamine is not released in other brain regions. Unlike other treatments, this approach targets the root cause of PD rather than just reducing symptoms.

Computer Science

What problem does this paper attempt to address?

The problem this paper attempts to address is the treatment challenge of Parkinson's Disease (PD). Specifically, Parkinson's Disease is a progressive neurodegenerative disorder primarily caused by the loss of dopaminergic neurons in the Basal Ganglia (BG). Currently, there is no cure for Parkinson's Disease, and existing treatments mainly aim to alleviate symptoms. Due to the impaired neurotransmitter-mediated information transmission caused by Parkinson's Disease, Molecular Communication (MC) has been proposed as a potential solution.

The paper proposes a novel treatment method based on molecular communication, namely the Intelligent Dopamine Rate Modulator (IDRM). The IDRM is located in the synaptic cleft between the Substantia Nigra Pars Compacta (SNc) and the Striatum, aiming to compensate for the insufficient dopamine release caused by Parkinson's Disease. Through this method, exogenous dopamine can be continuously supplemented to the Basal Ganglia, thereby reducing drug side effects. Unlike existing treatments, this method targets the root cause of Parkinson's Disease rather than merely alleviating symptoms.

The main contributions of the paper include:
1. **Design and Implementation of IDRM**: A detailed introduction to the design principles and mechanisms of IDRM, including the storage, detection, and release system of dopamine.
2. **Drug Delivery System (DDS)**: Discussion on how to deliver the Dopamine Compound (DAC) to the IDRM, ensuring its effective absorption and conversion in the brain.
3. **Mathematical Modeling**: Detailed mathematical modeling of the concentration changes of DAC in the digestive system, circulatory system, Blood-Brain Barrier (BBB), and brain extracellular matrix to verify its feasibility and effectiveness.

In summary, this paper aims to develop a new method that can effectively treat Parkinson's Disease through molecular communication technology, fundamentally addressing the issue of dopamine deficiency.